GlaxoSmithKline plc (LON:GSK) had its price objective hoisted by equities research analysts at Berenberg Bank from GBX 1,850 ($22.85) to GBX 1,890 ($23.34) in a report issued on Friday. The firm currently has a “hold” rating on the stock. Berenberg Bank’s price objective would indicate a potential upside of 11.93% from the stock’s previous close.

Other equities analysts have also issued reports about the company. Beaufort Securities restated a “buy” rating on shares of GlaxoSmithKline plc in a research report on Monday, December 5th. Goldman Sachs Group Inc restated a “buy” rating on shares of GlaxoSmithKline plc in a research report on Thursday, December 1st. HSBC Holdings plc restated a “buy” rating and set a GBX 1,970 ($24.33) target price on shares of GlaxoSmithKline plc in a research report on Tuesday, December 13th. Liberum Capital restated a “buy” rating and set a GBX 1,900 ($23.47) target price on shares of GlaxoSmithKline plc in a research report on Tuesday, December 20th. Finally, Jefferies Group LLC restated a “buy” rating and set a GBX 1,700 ($21.00) target price (down from GBX 1,850 ($22.85)) on shares of GlaxoSmithKline plc in a research report on Monday, December 19th. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and eight have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of GBX 1,744.73 ($21.55).

Analyst Recommendations for GlaxoSmithKline plc (LON:GSK)

Shares of GlaxoSmithKline plc (LON:GSK) opened at 1678.50 on Friday. The firm’s 50-day moving average is GBX 1,626.62 and its 200 day moving average is GBX 1,592.90. GlaxoSmithKline plc has a 1-year low of GBX 1,363.00 and a 1-year high of GBX 1,745.56. The stock’s market capitalization is GBX 81.71 billion.

The business also recently disclosed a dividend, which will be paid on Thursday, April 13th. Stockholders of record on Thursday, February 23rd will be paid a dividend of GBX 23 ($0.28) per share. The ex-dividend date of this dividend is Thursday, February 23rd. This represents a dividend yield of 1.47%. This is a boost from GlaxoSmithKline plc’s previous dividend of $19.00.

Your IP Address:

In related news, insider Vivienne Cox acquired 342 shares of the company’s stock in a transaction dated Wednesday, February 8th. The shares were bought at an average price of GBX 1,555 ($19.20) per share, for a total transaction of £5,318.10 ($6,567.99). Also, insider Moncef Slaoui acquired 56 shares of the company’s stock in a transaction dated Tuesday, March 7th. The shares were bought at an average price of GBX 2,072 ($25.59) per share, for a total transaction of £1,160.32 ($1,433.02). In the last quarter, insiders have bought 471 shares of company stock worth $786,697 and have sold 52,038 shares worth $84,442,106.

GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.

Receive News & Stock Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related stocks with our FREE daily email newsletter.